News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
ASCO – Rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
Photo taken from ASCO
May 22, 2024, 13:29

ASCO – Rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer

ASCO shared a post on LinkedIn:

“Check out our latest rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors.”

Read further.
Source: ASCO/LinkedIn

adjuvant chemotherapy ASCO Breast Cancer cancer OncoDaily Oncology Targeted Therap
Special Coverage
Drugs
Aug 5, 2025, 17:18
Sakditad Saowapa: A Promising Targeted Option for Leptomeningeal Metastases from Solid Tumors
Insight
Aug 5, 2025, 16:29
Building a Stronger Global Community to Take Action Against Cancer - UICC
Blog
Aug 5, 2025, 16:13
Al-Ola Abdallah: Daniel Carrizosa Discussed Bispecific T-cell Engagers in SCLC at National ICE-T Conference
Science
Aug 5, 2025, 16:07
Hagop Kantarjian: Discussing the Biology of Acute Lymphocytic Leukaemia
Blog
Aug 5, 2025, 16:04
Loizos G. Loizou: ELPIDA Foundation for Children with Cancer and Leukaemia
Blog
Aug 5, 2025, 15:57
Fabio Ynoe de Moraes: Radiotherapy Can "Heat Up" Cold Lung Tumors and Boost Immunotherapy Responses
Blog
Aug 5, 2025, 15:32
Sumanta Pal: Our Terrific Surgeons are Blazing New Trails for Challenging to Treat Diseases
Opinion
Aug 5, 2025, 15:01
Timothy Winschel: Excited to Share Our Recent Paper Published in Supportive Care in Cancer
Career
Aug 5, 2025, 14:16
Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology
Blog
Aug 5, 2025, 13:23
Can Exercise Change Cancer Care?
Immune Oncology
Aug 5, 2025, 13:09
FDA Fast Track for CLD-201: Stem Cell–Based Oncolytic Virus for Soft Tissue Sarcoma
Insight
Aug 5, 2025, 12:52
Chris Boshoff: Pfizer’s Updates from the Second Quarter